Cures Within Reach

Clinical trial funding available! We've opened our 2026 AI Validation RFP to fund clinical trials in any disease area that validate AI predictions of disease-drug repurposing matches. LOI submission deadline: June 26. Have questions? Join one of our AI Validation RFP info sessions! RFP details:
- Investigator-initiated Phase I/IIA clinical trials in any unsolved disease
- Led by a PI from a nonprofit academic / research institution based anywhere in the world
- Using already approved drugs, biologics and eligible cellular/gene therapies, whether on or off-patent
- Submission must include AI model data as part of required preclinical supporting evidence
- More information and how to start a submission are available at https://bit.ly/cwrrfps
Thanks to partners Biohub and Lyda Hill Philanthropies.

Apply for funding in our 4 open RFPs including Veterans and AI Validation. Learn about our new Chicago trials. Read the The Chronicle of Philanthropy feature. Meet our April Researcher Spotlight: Dr. Roch Christian Johnson of Université d'Abomey-Calavi in Benin - all in our April newsletter - found here: https://bit.ly/4e9gtyA.

Apply for clinical trial funding! Our 2026 LMIC, Chicago and Veterans RFPs are open for submissions. Read about these and our 6 recently selected AI Validation clinical trials plus meet our March Researcher Spotlight: Dr. Lixin Zhang of Dent Neurologic Institute in our March newsletter: https://bit.ly/3Nmqbm9

On , we celebrate patients and caregivers. Our selection of 6 new clinical trials to validate AI-driven drug-disease predictions, including 3 trials focused on rare/ultra-rare diseases, represents a pivotal step in turning powerful computational predictions into real treatments for patients. By combining AI insights with real-world clinical validation, these trials aim to accelerate access to therapies and bring new hope to patients who have long had none. Because in rare diseases, speed matters.

https://www.cureswithinreach.org/2026/02/25/press-release-cures-within-reach-selected-three-clinical-trials-in-rare-ultrarare/

Biohub Channeling Hope Foundation Jeremy Tanner Tyler Beck National Center for Advancing Translational Sciences Lyda Hill Philanthropies Nicole Small National Organization for Rare Disorders, Inc. (NORD) Global Genes EURORDIS-Rare Diseases Europe Canadian Organization for Rare Disorders Rare Disease Day